Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the K

Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the K

Item

http://www.wikidata.org/entity/Q34196366

Q34196366

about

Gene therapy for ischemic heart disease Gene Therapy in Cardiac Surgery: Clinical Trials, Challenges, and Perspectives A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiforme The physiology of cardiovascular disease and innovative liposomal platforms for therapy Microvascular repair: post-angiogenesis vascular dynamics Therapeutic angiogenesis: controlled delivery of angiogenic factors.Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting Molecules Nanoparticulate carriers for the treatment of coronary restenosis VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention Systems biology of pro-angiogenic therapies targeting the VEGF system Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis.Perspectives and opportunities for nanomedicine in the management of atherosclerosis.Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.Angiomyogenesis for myocardial repair.Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand?Reversal of myocardial injury using genetically modulated human skeletal myoblasts in a rodent cryoinjured heart model.Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide.Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis.Heart failure management: the present and the future.High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy The road ahead: working towards effective clinical translation of myocardial gene therapies.Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5.Vascular endothelial growth factor signaling in hypoxia and inflammation.Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress.The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A.Blood vessel repair and regeneration in the ischaemic heart Effects of local gene transfer of VEGF on neointima formation after balloon injury in hypercholesterolemic rabbits.Tomato thymidine kinase-based suicide gene therapy for malignant glioma--an alternative for Herpes Simplex virus-1 thymidine kinase.Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application.Intravascular magnetic resonance/radiofrequency may enhance gene therapy for prevention of in-stent neointimal hyperplasia.Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer.The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction.Update on gene therapy for myocardial ischaemia and left ventricular systolic dysfunction or heart failure.Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease.Development of viral vectors for use in cardiovascular gene therapy.Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine.Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia.

P2860

Q24632135-221B5883-F1DC-4058-90DB-72B481C0ABF6 Q26769595-702BE83A-C6A7-4E6F-8400-78C07228F674 Q26849375-39E8727F-A124-423B-B70E-B5CFD8F15E50 Q27002949-72E53098-0256-495D-B97F-8F7651241706 Q27004093-A3B7389D-BA1F-4E71-9F94-87E33618196C Q27023731-A28291AD-8019-4DE6-825D-16FEE8578B48 Q27303518-38765D71-D289-4D59-B75C-A37ADA72D7DB Q28220309-C29691E7-D5E9-4DB1-8D4F-935F7A505118 Q28260984-9512D4CE-1D53-40AC-B607-60FE4362935A Q28654633-03A66FBC-2EE8-487B-86F7-768E5FD689F0 Q30430112-6EF386E5-7B10-4D45-9B39-8F9E65DE96F6 Q30438396-A1986247-60A9-4EF5-82A1-6E03F76D70FB Q30455490-8CDF07B3-0DF2-4F88-A7A4-4613D104EC29 Q30475719-0DF8AD60-72F0-4938-BF6F-5D2617A0C6F9 Q30480151-DCF48E42-9B34-40B8-8218-C9966CDF6216 Q30489689-94E79A3F-741F-4BB7-A7C7-3B1380C2C688 Q33224509-62BC4C6E-9D29-4716-941F-490FB68DEF1C Q33410559-FBDF5CC7-EAD2-417D-9635-DD0DDE61B8CB Q33517020-7D1BEBDE-B646-4EA8-AF35-5E8F2664E342 Q33605156-3516FB8E-54BF-4924-99A5-31C867B39FD1 Q33670765-75F217E1-721B-4809-B962-20608E9ECA86 Q33705144-34574819-0AC8-40EA-B87F-5DE245BBF4D0 Q33711997-13733480-18E1-4FA7-8ED5-2C8110F488FE Q33721685-EF5380E0-3041-438B-AEFD-D0FD6FD2D8F0 Q33765479-A944179C-3F44-4D82-B150-426B1E0BF15F Q33983876-A64BA71E-1EA2-4882-951E-E4B58733702A Q34007727-DF95B3E9-E953-4A22-A0B1-4EAA9A9D9419 Q34304413-53FD68C2-BB99-429A-ADBB-9ECDB5FA6579 Q34429250-4B8583BE-707F-4DA9-850C-BA5B95287D4B Q34459264-363FD7EB-6C73-4D5A-A976-D64FC2ABD173 Q34469627-B306CEB7-A955-4D39-8C21-BAB3B52A52C0 Q34478326-7CEB4F9A-0E2F-4165-BBEE-8776505BBF7E Q34943604-D9A3285D-B2C1-41B6-A1B4-3D94AF454164 Q35015659-36ED7A5C-05EB-4857-AF83-5187F6664584 Q35069550-020AB9B8-CA76-4A16-8E4D-A2012DB47D83 Q35069886-EB1787E2-7EB6-439F-B416-38ECA3FFE203 Q35070251-A62636C7-4DE1-4DAE-9DB0-E1DDCDEC667D Q35260617-BC20E8ED-733B-4205-94F8-5F383F590D87 Q35319305-447F09AB-0C90-406F-959E-5D5BC143D56A Q35582797-5B9EDFDC-01E7-4147-86A6-AAEE224AF487

P2860

Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the K

Item

http://www.wikidata.org/entity/Q34196366

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu